chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Night sweats
Clinical narrative: Adverse event; night sweats; he couldn't even walk 100 meters; very very ill; fatigue/absolute sapping fatigue; joint pian; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Adverse event), NIGHT SWEATS (night sweats), GAIT INABILITY (he couldn't even walk 100 meters), ILLNESS (very very ill) and FATIGUE (fatigue/absolute sapping fatigue) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Adverse event), NIGHT SWEATS (night sweats), GAIT INABILITY (he couldn't even walk 100 meters), ILLNESS (very very ill), FATIGUE (fatigue/absolute sapping fatigue) and ARTHRALGIA (joint pian). At the time of the report, ADVERSE EVENT (Adverse event) outcome was unknown and NIGHT SWEATS (night sweats), GAIT INABILITY (he couldn't even walk 100 meters), ILLNESS (very very ill), FATIGUE (fatigue/absolute sapping fatigue) and ARTHRALGIA (joint pian) had resolved. Not Provided          No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-114923 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Added E-mail address. Added Event information- Night sweats, gait inability, illness, fatigue, arthralgia.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 103 fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (103 fever) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (103 fever). At the time of the report, PYREXIA (103 fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment of events was not reported. Concomitant medication use was not provided by the reporter.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: General Body aches; Pain in arm; Fatigue; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (General Body aches), PAIN IN EXTREMITY (Pain in arm), FATIGUE (Fatigue) and HEADACHE (Headaches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C31A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced PAIN (General Body aches), PAIN IN EXTREMITY (Pain in arm), FATIGUE (Fatigue) and HEADACHE (Headaches). At the time of the report, PAIN (General Body aches), PAIN IN EXTREMITY (Pain in arm), FATIGUE (Fatigue) and HEADACHE (Headaches) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Gait inability
Clinical narrative: Can not stand on her own; Light Headed; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (Can not stand on her own) and DIZZINESS (Light Headed) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced GAIT INABILITY (Can not stand on her own) and DIZZINESS (Light Headed). At the time of the report, GAIT INABILITY (Can not stand on her own) and DIZZINESS (Light Headed) outcome was unknown.            The patient reported use of concomitant medications but did not provide any details. No treatment information was reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Malaise, Myalgia, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever) and myalgia (body aches) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 027B21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Apr 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On May 7, 2021, patient experienced pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever), myalgia (body aches) and headache. At the time of the report, pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever), myalgia (body aches) and headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever) and myalgia (body aches) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 027B21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Apr 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On May 7, 2021, patient experienced pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever), myalgia (body aches) and headache. At the time of the report, pain in extremity (pain on the right arm), malaise (not feeling well), insomnia (couldn't sleep), pyrexia (fever), myalgia (body aches) and headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: vaccination site burning; vaccination site pain; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE PAIN (vaccination site burning) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriasis.    Concurrent medical conditions included Psoriasis. Concomitant products included HYDROCORTISONE and LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETRIZINE HYDROCHLORIDE) for an unknown indication.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg. In February 2021, the patient experienced VACCINATION SITE PAIN (vaccination site pain). On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site burning). At the time of the report, VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE PAIN (vaccination site burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE PAIN (vaccination site burning) to be not related.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-1 test
Clinical narrative: Second dose 65 days apart from the first vaccination; Tested positive for COVID-19, had very mild symptoms; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19, had very mild symptoms) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 65 days apart from the first vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced COVID-19 (Tested positive for COVID-19, had very mild symptoms) (seriousness criterion medically significant). On 07-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 65 days apart from the first vaccination) (seriousness criterion medically significant). On 03-May-2021, COVID-19 (Tested positive for COVID-19, had very mild symptoms) had resolved. On 07-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose 65 days apart from the first vaccination) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, SARS-CoV-1 test: positive (Positive) Positive. On 03-May-2021, SARS-CoV-1 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment of these events were not reported.; Sender's Comments: The causality for the events is "Not Applicable"
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: A rash at the injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE RASH (A rash at the injection site) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (A rash at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at a dose of 1 dosage form and DEXAMETHASONE (DECADRON [DEXAMETHASONE]) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE RASH (A rash at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  The physician was recommended to the patient not to get the second dose.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Mobility decreased, Swelling
Clinical narrative: Something came out between the axilla and my chest; I try to lower my arm, I can't because the ball is there; I could not sleep because I feel the ball; Headache; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Something came out between the axilla and my chest), MOBILITY DECREASED (I try to lower my arm, I can't because the ball is there), INSOMNIA (I could not sleep because I feel the ball) and HEADACHE (Headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included GABAPENTIN, TOPIRAMATE (TOPAMAX) and SULFAMETHOXAZOLE, TRIMETHOPRIM (SULFAMETHOXAZOLE AND TRIMETHOPRIM) for an unknown indication.    On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced SWELLING (Something came out between the axilla and my chest), MOBILITY DECREASED (I try to lower my arm, I can't because the ball is there), INSOMNIA (I could not sleep because I feel the ball) and HEADACHE (Headache). At the time of the report, SWELLING (Something came out between the axilla and my chest), MOBILITY DECREASED (I try to lower my arm, I can't because the ball is there), INSOMNIA (I could not sleep because I feel the ball) and HEADACHE (Headache) outcome was unknown.            Treatment: Patient is taking Ibuprofen 200mg 2 tablets PO every 6 hours   This case was linked to US-MODERNATX, INC.-MOD-2021-114900 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114900:First dose case
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: general fatigue; soreness around the injection site; headache got increasingly worse, near the back of the head, which exacerbated her movement,; Shoulder pain; muscle aches; body aches; a really bad headache; nauseated; neck pain; neck muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (general fatigue), NECK PAIN (neck pain), MYALGIA (neck muscle pain), VACCINATION SITE PAIN (soreness around the injection site) and NAUSEA (nauseated) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced NECK PAIN (neck pain), MYALGIA (neck muscle pain) and NAUSEA (nauseated). On 07-May-2021, the patient experienced HEADACHE (a really bad headache). On 08-May-2021, the patient experienced MYALGIA (muscle aches) and PAIN (body aches). On an unknown date, the patient experienced FATIGUE (general fatigue), VACCINATION SITE PAIN (soreness around the injection site), HEADACHE (headache got increasingly worse, near the back of the head, which exacerbated her movement,) and ARTHRALGIA (Shoulder pain). On 09-May-2021, HEADACHE (a really bad headache) had resolved. At the time of the report, FATIGUE (general fatigue), NECK PAIN (neck pain), MYALGIA (neck muscle pain), VACCINATION SITE PAIN (soreness around the injection site), NAUSEA (nauseated), HEADACHE (headache got increasingly worse, near the back of the head, which exacerbated her movement,), ARTHRALGIA (Shoulder pain), MYALGIA (muscle aches) and PAIN (body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain, Vaccination site pain
Clinical narrative: general fatigue; soreness around the injection site; headache got increasingly worse, near the back of the head, which exacerbated her movement,; Shoulder pain; muscle aches; body aches; a really bad headache; nauseated; neck pain; neck muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (general fatigue), NECK PAIN (neck pain), MYALGIA (neck muscle pain), VACCINATION SITE PAIN (soreness around the injection site) and NAUSEA (nauseated) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced NECK PAIN (neck pain), MYALGIA (neck muscle pain) and NAUSEA (nauseated). On 07-May-2021, the patient experienced HEADACHE (a really bad headache). On 08-May-2021, the patient experienced MYALGIA (muscle aches) and PAIN (body aches). On an unknown date, the patient experienced FATIGUE (general fatigue), VACCINATION SITE PAIN (soreness around the injection site), HEADACHE (headache got increasingly worse, near the back of the head, which exacerbated her movement,) and ARTHRALGIA (Shoulder pain). On 09-May-2021, HEADACHE (a really bad headache) had resolved. At the time of the report, FATIGUE (general fatigue), NECK PAIN (neck pain), MYALGIA (neck muscle pain), VACCINATION SITE PAIN (soreness around the injection site), NAUSEA (nauseated), HEADACHE (headache got increasingly worse, near the back of the head, which exacerbated her movement,), ARTHRALGIA (Shoulder pain), MYALGIA (muscle aches) and PAIN (body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Euphoric mood
Clinical narrative: feeling high; This spontaneous case was reported by a consumer and describes the occurrence of EUPHORIC MOOD (feeling high) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EUPHORIC MOOD (feeling high). At the time of the report, EUPHORIC MOOD (feeling high) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.  Patient was in the age group of 40-50 years.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain
Clinical narrative: Rash; Pain at the injection site; This spontaneous case was reported by a patient and describes the occurrence of RASH (Rash) and VACCINATION SITE PAIN (Pain at the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced RASH (Rash) and VACCINATION SITE PAIN (Pain at the injection site). At the time of the report, RASH (Rash) and VACCINATION SITE PAIN (Pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.   This case was linked to MOD-2021-024194 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Pain, Pain in extremity, Renal pain, Vaccination site pain
Clinical narrative: whole body hurts; muscular type of pain in legs (feels like you've played basketball for four hours after not having; pain around kidney area in the right side of my back; major pain can't bend over and is hard to get back up; pain in arms; Left arm hurt at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm hurt at the injection site), PAIN (whole body hurts), PAIN IN EXTREMITY (muscular type of pain in legs (feels like you've played basketball for four hours after not having), RENAL PAIN (pain around kidney area in the right side of my back) and MUSCULOSKELETAL DISCOMFORT (major pain can't bend over and is hard to get back up) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE PAIN (Left arm hurt at the injection site). On 05-May-2021, the patient experienced PAIN (whole body hurts), PAIN IN EXTREMITY (muscular type of pain in legs (feels like you've played basketball for four hours after not having), RENAL PAIN (pain around kidney area in the right side of my back), MUSCULOSKELETAL DISCOMFORT (major pain can't bend over and is hard to get back up) and PAIN IN EXTREMITY (pain in arms). At the time of the report, VACCINATION SITE PAIN (Left arm hurt at the injection site), PAIN (whole body hurts), PAIN IN EXTREMITY (muscular type of pain in legs (feels like you've played basketball for four hours after not having), RENAL PAIN (pain around kidney area in the right side of my back), MUSCULOSKELETAL DISCOMFORT (major pain can't bend over and is hard to get back up) and PAIN IN EXTREMITY (pain in arms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Myalgia, Pain in extremity
Clinical narrative: pain to my upper body arms, muscles and shoulders; have a slight problem with my back. This vaccine intensived the problem; pain to my upper body arms, muscles and shoulders; pain to my upper body arms, muscles and shoulders; Knee pain agravated; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (pain to my upper body arms, muscles and shoulders), BACK PAIN (have a slight problem with my back. This vaccine intensived the problem), MYALGIA (pain to my upper body arms, muscles and shoulders), ARTHRALGIA (pain to my upper body arms, muscles and shoulders) and ARTHRALGIA (Knee pain agravated) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Knee pain (Received cortisone shot.) and Back pain.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain to my upper body arms, muscles and shoulders), BACK PAIN (have a slight problem with my back. This vaccine intensived the problem), MYALGIA (pain to my upper body arms, muscles and shoulders), ARTHRALGIA (pain to my upper body arms, muscles and shoulders) and ARTHRALGIA (Knee pain agravated). At the time of the report, PAIN IN EXTREMITY (pain to my upper body arms, muscles and shoulders), BACK PAIN (have a slight problem with my back. This vaccine intensived the problem), MYALGIA (pain to my upper body arms, muscles and shoulders), ARTHRALGIA (pain to my upper body arms, muscles and shoulders) and ARTHRALGIA (Knee pain agravated) had not resolved.            No concomitant medications were reported.  Treatment details included 2 Tylenol pills for every four hours in order to function.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Erythema, Pain, Pruritus, Rash
Clinical narrative: Weakness; Sleepiness for 3 days; Rash from shoulder to elbow; Pain; Redness; Iching; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), ERYTHEMA (Redness), PRURITUS (Iching), ASTHENIA (Weakness) and SOMNOLENCE (Sleepiness for 3 days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fatty liver in 2020. Concurrent medical conditions included Drug allergy (Asprin allergy), Spinal stenosis since 1980, Tremor (Benigh tremmors) since 1989, Diabetes since 2020, Blood pressure high (High blood pressure) since 1980, Asthma since 1980, Osteoarthritis since 1989 and Tachycardia since 1989. Concomitant products included INSULIN DEGLUDEC (TRESIBA), INSULIN LISPRO (HUMALOG), ALBUTEROL SULFATE;IPRATROPIUM BROMIDE, METOPROLOL, METHOCARBAMOL, LISINOPRIL, CODEINE PHOSPHATE, PARACETAMOL (TYLENOL WITH CODEINE), GLIPIZIDE, METFORMIN HYDROCHLORIDE (GLIPIZIDE/METFORMIN) and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.   On 24-Feb-2021 at 9:16 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021 at 9:10 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced PAIN (Pain) and PRURITUS (Iching). 25-Mar-2021, the patient experienced ERYTHEMA (Redness) and RASH (Rash from shoulder to elbow). On 25-Mar-2021 at 1:10 PM, the patient experienced ASTHENIA (Weakness) and SOMNOLENCE (Sleepiness for 3 days). On 28-Mar-2021, ASTHENIA (Weakness) and SOMNOLENCE (Sleepiness for 3 days) had resolved. On 30-Mar-2021, PAIN (Pain), ERYTHEMA (Redness), PRURITUS (Iching) and RASH (Rash from shoulder to elbow) had resolved.            The treatment medication was not reported   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional document added on 25 Jun 2021 was the Email attachment of the case and had no new information.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Weakness; Sleepiness for 3 days; Rash from shoulder to elbow; Pain; Redness; Iching; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), ERYTHEMA (Redness), PRURITUS (Iching), ASTHENIA (Weakness) and SOMNOLENCE (Sleepiness for 3 days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fatty liver in 2020. Concurrent medical conditions included Drug allergy (Asprin allergy), Spinal stenosis since 1980, Tremor (Benigh tremmors) since 1989, Diabetes since 2020, Blood pressure high (High blood pressure) since 1980, Asthma since 1980, Osteoarthritis since 1989 and Tachycardia since 1989. Concomitant products included INSULIN DEGLUDEC (TRESIBA), INSULIN LISPRO (HUMALOG), ALBUTEROL SULFATE;IPRATROPIUM BROMIDE, METOPROLOL, METHOCARBAMOL, LISINOPRIL, CODEINE PHOSPHATE, PARACETAMOL (TYLENOL WITH CODEINE), GLIPIZIDE, METFORMIN HYDROCHLORIDE (GLIPIZIDE/METFORMIN) and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.   On 24-Feb-2021 at 9:16 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021 at 9:10 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced PAIN (Pain) and PRURITUS (Iching). 25-Mar-2021, the patient experienced ERYTHEMA (Redness) and RASH (Rash from shoulder to elbow). On 25-Mar-2021 at 1:10 PM, the patient experienced ASTHENIA (Weakness) and SOMNOLENCE (Sleepiness for 3 days). On 28-Mar-2021, ASTHENIA (Weakness) and SOMNOLENCE (Sleepiness for 3 days) had resolved. On 30-Mar-2021, PAIN (Pain), ERYTHEMA (Redness), PRURITUS (Iching) and RASH (Rash from shoulder to elbow) had resolved.            The treatment medication was not reported   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional document added on 25 Jun 2021 was the Email attachment of the case and had no new information.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Glassy eyes, Nasal discomfort, Vaccination site erythema, Vaccination site pain
Clinical narrative: Burning sensation in nose after the 1st dose; Eyes were blurry after the 1st dose; Burning sensation in eyes after the 1st dose; Eyes looked glassy after the 1st dose; Itchy at injection site after the 1st dose; Big red square around injection site after 1st dose/ Looks like red band-aid around injection site after the 1st dose; Sore at injection site after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of NASAL DISCOMFORT (Burning sensation in nose after the 1st dose), VISION BLURRED (Eyes were blurry after the 1st dose), EYE IRRITATION (Burning sensation in eyes after the 1st dose), GLASSY EYES (Eyes looked glassy after the 1st dose) and VACCINATION SITE PRURITUS (Itchy at injection site after the 1st dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036b219) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Reaction to previous exposure to any vaccine.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL DISCOMFORT (Burning sensation in nose after the 1st dose), VISION BLURRED (Eyes were blurry after the 1st dose), EYE IRRITATION (Burning sensation in eyes after the 1st dose), GLASSY EYES (Eyes looked glassy after the 1st dose), VACCINATION SITE PRURITUS (Itchy at injection site after the 1st dose), VACCINATION SITE ERYTHEMA (Big red square around injection site after 1st dose/ Looks like red band-aid around injection site after the 1st dose) and VACCINATION SITE PAIN (Sore at injection site after the 1st dose). At the time of the report, NASAL DISCOMFORT (Burning sensation in nose after the 1st dose), VISION BLURRED (Eyes were blurry after the 1st dose), EYE IRRITATION (Burning sensation in eyes after the 1st dose), GLASSY EYES (Eyes looked glassy after the 1st dose), VACCINATION SITE PRURITUS (Itchy at injection site after the 1st dose), VACCINATION SITE ERYTHEMA (Big red square around injection site after 1st dose/ Looks like red band-aid around injection site after the 1st dose) and VACCINATION SITE PAIN (Sore at injection site after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vision blurred
Clinical narrative: Burning sensation in nose after the 1st dose; Eyes were blurry after the 1st dose; Burning sensation in eyes after the 1st dose; Eyes looked glassy after the 1st dose; Itchy at injection site after the 1st dose; Big red square around injection site after 1st dose/ Looks like red band-aid around injection site after the 1st dose; Sore at injection site after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of NASAL DISCOMFORT (Burning sensation in nose after the 1st dose), VISION BLURRED (Eyes were blurry after the 1st dose), EYE IRRITATION (Burning sensation in eyes after the 1st dose), GLASSY EYES (Eyes looked glassy after the 1st dose) and VACCINATION SITE PRURITUS (Itchy at injection site after the 1st dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036b219) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Reaction to previous exposure to any vaccine.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL DISCOMFORT (Burning sensation in nose after the 1st dose), VISION BLURRED (Eyes were blurry after the 1st dose), EYE IRRITATION (Burning sensation in eyes after the 1st dose), GLASSY EYES (Eyes looked glassy after the 1st dose), VACCINATION SITE PRURITUS (Itchy at injection site after the 1st dose), VACCINATION SITE ERYTHEMA (Big red square around injection site after 1st dose/ Looks like red band-aid around injection site after the 1st dose) and VACCINATION SITE PAIN (Sore at injection site after the 1st dose). At the time of the report, NASAL DISCOMFORT (Burning sensation in nose after the 1st dose), VISION BLURRED (Eyes were blurry after the 1st dose), EYE IRRITATION (Burning sensation in eyes after the 1st dose), GLASSY EYES (Eyes looked glassy after the 1st dose), VACCINATION SITE PRURITUS (Itchy at injection site after the 1st dose), VACCINATION SITE ERYTHEMA (Big red square around injection site after 1st dose/ Looks like red band-aid around injection site after the 1st dose) and VACCINATION SITE PAIN (Sore at injection site after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Feeling abnormal, Nausea
Clinical narrative: Dizzy; Weak; Weird Feeling; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), ASTHENIA (Weak), FEELING ABNORMAL (Weird Feeling) and NAUSEA (Nauseous) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced DIZZINESS (Dizzy), ASTHENIA (Weak), FEELING ABNORMAL (Weird Feeling) and NAUSEA (Nauseous). At the time of the report, DIZZINESS (Dizzy), ASTHENIA (Weak), FEELING ABNORMAL (Weird Feeling) and NAUSEA (Nauseous) outcome was unknown.            She mentioned she is taking concomitant medication but no concomitant medications were mentioned. No treatment drugs were reported.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose was not applied in the recommended interval (40 days since first dose); This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose was not applied in the recommended interval (40 days since first dose)) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose was not applied in the recommended interval (40 days since first dose)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose was not applied in the recommended interval (40 days since first dose)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   patient that has an upcoming hip replacement surgery soon patient's doctor didn't want for the patient to get the second dose before the surgery.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Swelling
Clinical narrative: flu like symptoms; gelatinous bump over collar bone pretty inflamed; extremely sore; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), SWELLING (gelatinous bump over collar bone pretty inflamed) and MYALGIA (extremely sore) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 002B21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included PHENTERMINE for an unknown indication.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), SWELLING (gelatinous bump over collar bone pretty inflamed) and MYALGIA (extremely sore). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), SWELLING (gelatinous bump over collar bone pretty inflamed) and MYALGIA (extremely sore) outcome was unknown.            Concomitant medications included Birth control medications.
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Fatigue, Hypokinesia, Illness
Clinical narrative: confused; sick; dizziness; can't think straight; can't stay awake; forgetful; can't move; sleeping all the time; throws up; extreme fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confused), ILLNESS (sick), DIZZINESS (dizziness), THINKING ABNORMAL (can't think straight) and SOMNOLENCE (can't stay awake) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included THYROID and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced CONFUSIONAL STATE (confused), ILLNESS (sick), DIZZINESS (dizziness), THINKING ABNORMAL (can't think straight), SOMNOLENCE (can't stay awake), MEMORY IMPAIRMENT (forgetful), HYPOKINESIA (can't move), SOMNOLENCE (sleeping all the time), VOMITING (throws up) and FATIGUE (extreme fatigue). At the time of the report, CONFUSIONAL STATE (confused), ILLNESS (sick), DIZZINESS (dizziness), THINKING ABNORMAL (can't think straight), SOMNOLENCE (can't stay awake), MEMORY IMPAIRMENT (forgetful), HYPOKINESIA (can't move), SOMNOLENCE (sleeping all the time), VOMITING (throws up) and FATIGUE (extreme fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided Antihistamine .
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Somnolence, Thinking abnormal, Vomiting
Clinical narrative: confused; sick; dizziness; can't think straight; can't stay awake; forgetful; can't move; sleeping all the time; throws up; extreme fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confused), ILLNESS (sick), DIZZINESS (dizziness), THINKING ABNORMAL (can't think straight) and SOMNOLENCE (can't stay awake) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included THYROID and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced CONFUSIONAL STATE (confused), ILLNESS (sick), DIZZINESS (dizziness), THINKING ABNORMAL (can't think straight), SOMNOLENCE (can't stay awake), MEMORY IMPAIRMENT (forgetful), HYPOKINESIA (can't move), SOMNOLENCE (sleeping all the time), VOMITING (throws up) and FATIGUE (extreme fatigue). At the time of the report, CONFUSIONAL STATE (confused), ILLNESS (sick), DIZZINESS (dizziness), THINKING ABNORMAL (can't think straight), SOMNOLENCE (can't stay awake), MEMORY IMPAIRMENT (forgetful), HYPOKINESIA (can't move), SOMNOLENCE (sleeping all the time), VOMITING (throws up) and FATIGUE (extreme fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided Antihistamine .
Age: 61.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Vaccination site warmth; Vaccination site erythema; Vaccination site pruritus; Vaccination site rash; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE RASH (Vaccination site rash) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE RASH (Vaccination site rash). At the time of the report, VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE RASH (Vaccination site rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported  No treatment medication was reported
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: extremely dizzy; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (extremely dizzy) and NAUSEA (nauseous) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 028A21A) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy and Allergic sinusitis. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergic sinusitis, METHYLSULFONYLMETHANE (MSM [METHYLSULFONYLMETHANE]) for Arthritis, DICLOFENAC for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced DIZZINESS (extremely dizzy) and NAUSEA (nauseous). At the time of the report, DIZZINESS (extremely dizzy) and NAUSEA (nauseous) outcome was unknown. Not Provided          It was reported that kind a sick for 3 days. No treatment was reported.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Rash
Clinical narrative: Redness; Pain in arm; rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PAIN IN EXTREMITY (Pain in arm) and RASH (rash) in a 48-year-old male patient who received mRNA-1273 (Moderna CoviD-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness), PAIN IN EXTREMITY (Pain in arm) and RASH (rash). At the time of the report, ERYTHEMA (Redness), PAIN IN EXTREMITY (Pain in arm) and RASH (rash) outcome was unknown.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: red injection site; warm injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm injection site) and VACCINATION SITE ERYTHEMA (red injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced VACCINATION SITE WARMTH (warm injection site). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red injection site). At the time of the report, VACCINATION SITE WARMTH (warm injection site) and VACCINATION SITE ERYTHEMA (red injection site) outcome was unknown.            No concomitants were reported. No treatment was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Non significant follow up - Reporter address updated.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nausea, Rhinorrhoea, Sneezing
Clinical narrative: Sneezing; Runny nose; Body aches; Fatigue; Moderate nausea/vomiting; Moderate nausea/vomiting; Soreness at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), RHINORRHOEA (Runny nose), MYALGIA (Body aches), FATIGUE (Fatigue) and NAUSEA (Moderate nausea/vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced SNEEZING (Sneezing), RHINORRHOEA (Runny nose), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Moderate nausea/vomiting), VOMITING (Moderate nausea/vomiting) and VACCINATION SITE PAIN (Soreness at the site of the injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Runny nose, at an unspecified dose and frequency. At the time of the report, SNEEZING (Sneezing) and RHINORRHOEA (Runny nose) had not resolved, MYALGIA (Body aches), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Soreness at the site of the injection) outcome was unknown and NAUSEA (Moderate nausea/vomiting) and VOMITING (Moderate nausea/vomiting) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.